CN114507221B - 一种三嗪类化合物及其在制备抗病毒药物上的用途 - Google Patents
一种三嗪类化合物及其在制备抗病毒药物上的用途 Download PDFInfo
- Publication number
- CN114507221B CN114507221B CN202210418619.9A CN202210418619A CN114507221B CN 114507221 B CN114507221 B CN 114507221B CN 202210418619 A CN202210418619 A CN 202210418619A CN 114507221 B CN114507221 B CN 114507221B
- Authority
- CN
- China
- Prior art keywords
- compound
- formula
- pharmaceutically acceptable
- stereoisomer
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (12)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210418619.9A CN114507221B (zh) | 2022-04-21 | 2022-04-21 | 一种三嗪类化合物及其在制备抗病毒药物上的用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210418619.9A CN114507221B (zh) | 2022-04-21 | 2022-04-21 | 一种三嗪类化合物及其在制备抗病毒药物上的用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114507221A CN114507221A (zh) | 2022-05-17 |
CN114507221B true CN114507221B (zh) | 2022-08-26 |
Family
ID=81555469
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210418619.9A Active CN114507221B (zh) | 2022-04-21 | 2022-04-21 | 一种三嗪类化合物及其在制备抗病毒药物上的用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114507221B (zh) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116655606A (zh) * | 2022-02-18 | 2023-08-29 | 广州谷森制药有限公司 | 新型氘代三嗪类化合物、其制备方法、组合物及应用 |
WO2023165459A1 (en) * | 2022-03-01 | 2023-09-07 | Fochon Biosciences , Ltd. | Compounds as sars-cov-2 inhibitors |
WO2023169572A1 (zh) * | 2022-03-10 | 2023-09-14 | 湖北九康通生物医药有限公司 | 一种三嗪类化合物、其中间体、其制备方法及其用途 |
CN114539228A (zh) * | 2022-03-14 | 2022-05-27 | 药康众拓(江苏)医药科技有限公司 | 三嗪类化合物或其可药用盐、异构体、药物组合物和用途 |
WO2023226679A1 (zh) * | 2022-05-27 | 2023-11-30 | 广州国家实验室 | 3c样蛋白酶抑制剂 |
WO2023227118A1 (zh) * | 2022-05-27 | 2023-11-30 | 广州国家实验室 | 3c样蛋白酶抑制剂 |
CN114805316B (zh) * | 2022-05-31 | 2024-04-26 | 中国药科大学 | 二酮氮杂环化合物或其可药用的盐、互变异构体及其制备方法、药物组合物及应用 |
CN115109041B (zh) * | 2022-06-07 | 2024-03-19 | 杭州科巢生物科技有限公司 | 一种3cl蛋白抑制剂恩赛特韦的合成方法及其中间体 |
CN114790198B (zh) * | 2022-06-24 | 2022-10-04 | 药康众拓(江苏)医药科技有限公司 | 一种三嗪类化合物及其制备方法和应用 |
US20240025885A1 (en) * | 2022-07-08 | 2024-01-25 | Ascletis BioScience Co., Ltd | Triazine derivatives and methods of use thereof |
CN116496266A (zh) * | 2022-07-08 | 2023-07-28 | 歌礼生物科技(杭州)有限公司 | 三嗪衍生物 |
CN115260166B (zh) * | 2022-07-13 | 2023-12-19 | 山东轩硕医药科技有限公司 | 一种高效合成s-217622的化学方法 |
CN114933594A (zh) * | 2022-07-20 | 2022-08-23 | 北京科翔中升医药科技有限公司 | 一种氟代三嗪类化合物、药物组合物及用途 |
CN115109042B (zh) * | 2022-08-30 | 2023-05-26 | 北京科翔中升医药科技有限公司 | 三嗪类化合物或其可药用的盐、药物组合物和用途 |
WO2024083099A1 (zh) * | 2022-10-18 | 2024-04-25 | 福建广生中霖生物科技有限公司 | 药物中间体及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114699419A (zh) * | 2020-06-08 | 2022-07-05 | 北京大学深圳研究生院 | PLpro蛋白抑制剂在治疗或预防新型冠状病毒感染的药物中的应用 |
WO2022035911A2 (en) * | 2020-08-11 | 2022-02-17 | Tutela Pharmaceuticals, Inc. | Methods of treating coronavirus infections by co-administering an fkbp ligand and an antiviral agent |
-
2022
- 2022-04-21 CN CN202210418619.9A patent/CN114507221B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN114507221A (zh) | 2022-05-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN114507221B (zh) | 一种三嗪类化合物及其在制备抗病毒药物上的用途 | |
WO2023173708A1 (zh) | 三嗪类化合物或其可药用盐、异构体、药物组合物和用途 | |
CN114790198B (zh) | 一种三嗪类化合物及其制备方法和应用 | |
TWI815396B (zh) | 具有病毒增殖抑制作用之三嗪衍生物及含有其等之醫藥組合物 | |
US20110269834A1 (en) | Compounds and methods for treating respiratory diseases | |
CN113072497B (zh) | 蛋白酶抑制剂、其制备和用途 | |
CN114805316B (zh) | 二酮氮杂环化合物或其可药用的盐、互变异构体及其制备方法、药物组合物及应用 | |
CN114933594A (zh) | 一种氟代三嗪类化合物、药物组合物及用途 | |
CN113620929B (zh) | 醛基类化合物及其制备方法、药物组合物和用途 | |
CN115109042B (zh) | 三嗪类化合物或其可药用的盐、药物组合物和用途 | |
CN112771048B (zh) | 流感病毒复制抑制剂及其中间体和用途 | |
CN115385984B (zh) | 一种拟肽类衍生物、制备方法和应用 | |
WO2004052879A1 (en) | Thiophenederivatives for the treatment of flavivirus infections | |
CN113754594A (zh) | 喹唑啉酮类化合物或其可药用的盐、异构体及其制备方法、药物组合物和用途 | |
CN114456211B (zh) | 一种拟肽类化合物及其制备方法和应用 | |
CN116003386A (zh) | 一种氘代n-苄基吡啶酮吡唑甲酰胺类化合物、药物组合物和用途 | |
CN111777638A (zh) | 喹啉类化合物、其制备方法、药物组合物和用途 | |
CN111995649A (zh) | 一种蝶啶酮核苷酸类似物及其药物组合物、制备方法和医药用途 | |
CN116648240A (zh) | 一种环肽类病毒蛋白酶抑制剂,其制备方法,及其在抗病毒药物中的应用 | |
CN116874471A (zh) | 一种氘代三嗪类化合物及其在抗病毒上的应用 | |
CN114105807B (zh) | 一种羟基环己二酰胺类化合物及其制备方法与应用 | |
CN115572294B (zh) | 一种氘代氮杂吲哚联吡唑类化合物、药物组合物和用途 | |
TWI832045B (zh) | 抗病毒性1,3-二氧代茚化合物 | |
CN117551039A (zh) | 一种芳基甲酰胺类化合物及其制备方法与抗肠道病毒ev71型的应用 | |
CN113773259A (zh) | 病毒主蛋白酶抑制剂及其制备方法和用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20220805 Address after: 224500 4th floor, North building, building 2, enterprise accelerator, Xin'an Avenue, Binhai Pharmaceutical Industrial Park, Binhai County, Yancheng City, Jiangsu Province Applicant after: Yaokang Zhongtuo (Jiangsu) Pharmaceutical Technology Co.,Ltd. Address before: 100036 Beijing city Haidian District Cuiwei Road No. 2, building A, room 1209, static source in Applicant before: Beijing Kexiang Zhongsheng Pharmaceutical Technology Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A Triazine Compound and Its Application in the Preparation of Antiviral Drugs Effective date of registration: 20220926 Granted publication date: 20220826 Pledgee: China Construction Bank Corporation Binhai Sub branch Pledgor: Yaokang Zhongtuo (Jiangsu) Pharmaceutical Technology Co.,Ltd. Registration number: Y2022980016528 |